Mast cell sarcoma: Difference between revisions
Jump to navigation
Jump to search
| Line 38: | Line 38: | ||
==Treatment== | ==Treatment== | ||
[[Mast cell sarcoma medical therapy|Medical Therapy]] | [[Mast cell sarcoma surgery|Surgery | [[Mast cell sarcoma medical therapy|Medical Therapy]] | [[Mast cell sarcoma surgery|Surgery]] | [[Mast cell sarcoma secondary prevention|Secondary Prevention]] | [[Mast cell sarcoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Mast cell sarcoma future or investigational therapies]] | ||
==Case Studies== | ==Case Studies== | ||
Revision as of 15:33, 12 September 2012
For patient information, click here
| Mast cell sarcoma | |
| ICD-10 | C96.2 |
|---|---|
| ICD-9 | 202.6 |
| ICD-O: | 9740/3 |
| MeSH | D012515 |
|
Mast cell sarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mast cell sarcoma On the Web |
|
American Roentgen Ray Society Images of Mast cell sarcoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Mast Cell Sarcoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Secondary Prevention | Cost-Effectiveness of Therapy | Mast cell sarcoma future or investigational therapies